Rephine is a leading provider of Good Manufacturing Practice (GMP) audits and regulatory consulting services to the pharmaceutical industry. The business has pioneered a differentiated approach to GMP auditing through its audit library model, solving common manufacturer and customer pain points caused by increasingly time-consuming and onerous auditing requirements. With pharmaceutical supply chains and regulations continuing to grow in complexity, the business is well-positioned to benefit from strong market tailwinds.
www.rephine.com
www.rephine.com
Location: United Kingdom, England
Investors 1
| Date | Name | Website |
| - | Kester Cap... | kestercapi... |
Mentions in press and media 3
| Date | Title | Description |
| 08.10.2024 | High-profile CEO appointment signals major new growth phase for class-leading pharmacovigilance specialist Qinecsa | Adam Sherlock Veteran safety & PV leader Adam Sherlock will capitalize on Qinecsa's deep domain expertise and comprehensive technology-powered solutions to pharma's most complex product safety challenges LONDON, Oct. 8, 2024 /PRNewswire... |
| 18.06.2024 | Rephine appoints Quality Assurance expert Robert Nurse as Chief Growth Officer as its global business goes from strength to strength | Robert Nurse, Chief Growth Officer In its latest service innovation, the respected life sciences QA and GxP compliance specialist will soon launch a new portal giving clients online instant access to their audits, as well as rich tools for ... |
| 06.07.2022 | Merger of Rephine with Forum Auditorias & TDV creates clear market leader in global GMP audit services | Rephine & TDV By combining the two best organisations in this sector, we are creating the clear market leader in our niche. STEVENAGE, United Kingdom (PRWEB) July 06, 2022 Rephine, a firm of deeply experienced GMP auditors specialising ... |